Comments
FDA rejects expanded use of Regeneron drug for gout
31.07.2012. | (Reuters) - Regeneron Pharmaceuticals Inc said U.S. regulators have denied approval for it to expand use of its Arcalyst drug to prevent gout flares, asking that the company provide more clinical data....
